Safety review to begin on topiramate -

Safety review to begin on topiramate - topiramate Topiramate for prophylaxis of migraine is already contraindicated in pregnancy and in women of childbearing potential not using highly effective topiramate We have initiated a new safety review into topiramate as a result of an observational study reporting an increased risk of

topiramate Information for healthcare professionals · It is already well known that topiramate can cause major congenital malformations and foetal growth

topiramate One of its side effects is hyperchloremic metabolic acidosis without anion gap,1,2 which can appear in up to 40% of the patients who receive topiramate at About topiramate Topiramate is a medicine used to treat epilepsy These are also called anti-epileptic medicines It can also be taken to help prevent migraine